bioMérieux is proud to bring you a unique symposium exploring perspectives on the value of molecular syndromic testing with Dr. Reem Almaghrabi, Dr. Luke Moore & Prof. Andrew Meltzer! We will discuss the value of genotypic resistance markers in severe infections, taking into account the local epidemiology, and explore how point-of-care syndromic testing supports antimicrobial stewardship for acute respiratory tract infections.
|